Sep 03, 2019
Starpharma’s VivaGel® BV regulatory approvals continue in Asia
Finance News Network reported Starpharma received further regulatory approval in another Asian country for its breakthrough product for bacterial vaginosis, VivaGel® BV. The news follows the first approval in the region announced on 15 August.
Read the full news coverage here.